Brennan Daniel J. (CIK 1595612) reported 23 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy MDGL (404 shares), Buy WAT (23 shares), Buy WAT (307 shares), Buy MDGL (967 shares), Sell BSX (2,900 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Buy | 404 | $0 |
| 2026-02-27 | WATERS CORP /DE/ (WAT) | Director | Buy | 23 | $0 |
| 2026-01-05 | WATERS CORP /DE/ (WAT) | Director | Buy | 307 | $0 |
| 2025-08-05 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Buy | 967 | $0 |
| 2025-02-19 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Sell | 2,900 | $301,832 |
| 2025-02-19 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Sell | 14,630 | $1.5M |
| 2025-02-19 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Buy | 18,533 | $454,985 |
| 2025-02-19 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Buy | 16,865 | $291,090 |
| 2025-02-19 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Buy | 15,642 | $423,742 |
| 2025-02-19 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Buy | 9,483 | $380,458 |
| 2025-02-19 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Sell | 67,333 | $7.1M |
| 2025-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Buy | 4,362 | $0 |
| 2025-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Sell | 2,110 | $223,892 |
| 2025-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Buy | 4,243 | $0 |
| 2025-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Sell | 2,052 | $217,738 |
| 2025-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Buy | 4,584 | $0 |
| 2025-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Sell | 2,217 | $235,246 |
| 2025-02-14 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Buy | 3,654 | $0 |
| 2025-02-14 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Sell | 1,767 | $186,896 |
| 2025-02-13 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Buy | 33,944 | $0 |
| 2025-02-13 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Sell | 16,414 | $1.7M |
| 2025-02-13 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Buy | 15,087 | $246,069 |
| 2025-02-13 | BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | Sell | 15,087 | $1.6M |
Source: SEC Form 4 filings · as of 2026-06-18